TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.420nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.620nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.770nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.770nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.890nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.900nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.910nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.920nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.940nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 0.950nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.10nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.10nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.20nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.20nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.20nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.20nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.30nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.30nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.30nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.30nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.30nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.40nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.40nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.5nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.60nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.60nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.60nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.60nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.60nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.70nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.70nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.70nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.70nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair